Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

7 structures for Q9UM11

Entry ID Method Resolution Chain Position Source
4UI9 EM 360 A R 1-496 PDB
5L9T EM 640 A R 1-496 PDB
5L9U EM 640 A R 1-496 PDB
7QE7 EM 290 A R 1-496 PDB
8TAR EM 400 A R 1-496 PDB
8TAU EM 350 A R 1-496 PDB
AF-Q9UM11-F1 Predicted AlphaFoldDB

278 variants for Q9UM11

Variant ID(s) Position Change Description Diseaes Association Provenance
VAR_087872 187 D>G DEE109; loss-of-function variant affecting cell cycle regulation; unable to rescue aberrant cell cycle in FZR1-deficient mouse cortical cells; decreased protein levels in patient cells [UniProt] Yes UniProt
TCGA novel
VAR_087873
187 D>N Variant assessed as Somatic; impact. DEE109; fails to rescue neurodevelopmental defects in a Drosophila model system; does not affect nuclear localization [NCI-TCGA, UniProt] Yes NCI-TCGA
UniProt
VAR_087874 333 N>K DEE109; fails to rescue neurodevelopmental defects in a Drosophila model system; does not affect nuclear localization [UniProt] Yes UniProt
CA9078077
rs749486120
3 Q>E No ClinGen
ExAC
gnomAD
CA9078078
rs771143636
5 Y>F No ClinGen
ExAC
gnomAD
rs1316114147
CA403325186
6 E>K No ClinGen
gnomAD
rs951021097
CA304376811
7 R>Q No ClinGen
gnomAD
CA9078079
rs371990144
7 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs745991748
CA9078080
11 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs772245619
CA9078081
11 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA304376817
rs1016659941
13 I>V No ClinGen
Ensembl
CA9078082
rs375035740
14 V>I No ClinGen
ESP
ExAC
gnomAD
CA9078083
rs375035740
14 V>L No ClinGen
ESP
ExAC
gnomAD
CA403325237
rs945817176
15 I>F No ClinGen
TOPMed
gnomAD
rs768911134
CA9078084
15 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA304376827
rs945817176
15 I>V No ClinGen
TOPMed
gnomAD
COSM474552
CA403325247
rs1160145563
16 Q>H kidney Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs776991909
CA9078085
18 E>D No ClinGen
ExAC
gnomAD
CA403325277
rs1400087632
20 T>M No ClinGen
TOPMed
gnomAD
CA9078087
rs765970647
21 M>V No ClinGen
ExAC
gnomAD
CA403325287
rs1454715253
22 P>A No ClinGen
gnomAD
rs371487179 23 R>= Variant assessed as Somatic; 4.622e-05 impact. [NCI-TCGA] No NCI-TCGA
CA9078088
rs369267353
23 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs759089831
CA9078089
23 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA403325332
rs1306607458
27 M>T No ClinGen
gnomAD
rs150420576
CA403325337
28 R>G No ClinGen
ESP
TOPMed
gnomAD
rs770204091
CA9078124
28 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs150420576
CA304378043
28 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
TOPMed
gnomAD
rs202131921
CA9078128
29 R>P No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9078127
rs202131921
29 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA9078126
rs377200001
29 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA9078130
rs768044432
32 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA9078134
rs765125004
34 A>G No ClinGen
ExAC
gnomAD
CA403325365
rs1213664354
34 A>P No ClinGen
TOPMed
CA9078133
rs765125004
34 A>V No ClinGen
ExAC
gnomAD
rs763294660
CA9078135
35 S>I No ClinGen
ExAC
gnomAD
rs1052945805
CA304378095
38 V>A No ClinGen
gnomAD
rs1274529465
CA403325389
38 V>L No ClinGen
TOPMed
rs766676061
CA9078136
39 S>P No ClinGen
ExAC
gnomAD
TCGA novel 40 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 42 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9078141
rs368356219
44 H>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1425769188
CA403325711
49 I>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA304378111
rs868008980
54 G>R No ClinGen
TOPMed
gnomAD
CA403325844
rs746625962
59 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs746625962
CA9078146
59 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1225766065
CA403325861
60 N>I No ClinGen
gnomAD
TCGA novel 61 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768223395 65 N>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs139197779
CA9078176
69 K>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs139197779
CA9078175
69 K>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA403326120
rs759834366
75 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs759834366
CA9078177
75 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA403326116
rs1265106596
75 R>W No ClinGen
gnomAD
CA403326151
rs1599783616
78 K>T No ClinGen
Ensembl
rs142885173
CA403326169
79 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs146055485
CA304378249
80 A>T No ClinGen
ESP
TOPMed
gnomAD
CA403326183
rs1599783630
81 T>P No ClinGen
Ensembl
rs374041533
CA9078181
84 N>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1200896420
CA403326237
85 G>A No ClinGen
gnomAD
rs754355403
CA9078182
85 G>S No ClinGen
ExAC
gnomAD
CA403326245
rs1432166598
86 K>T No ClinGen
gnomAD
rs777457646
CA9078208
88 G>S Variant assessed as Somatic; 4.766e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs753239356
CA9078209
COSM1686278
88 G>V skin [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1297236926
CA403326333
90 A>D No ClinGen
gnomAD
CA403326407
rs1342425757
96 K>R No ClinGen
TOPMed
CA9078213
rs771866008
103 G>D No ClinGen
ExAC
gnomAD
CA403326481
rs1465019235
103 G>S No ClinGen
TOPMed
gnomAD
CA403326509
rs1446224791
105 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA403326510
rs1446224791
105 E>Q No ClinGen
gnomAD
rs1163667730
CA403326542
107 V>L No ClinGen
gnomAD
CA403326538
rs1163667730
107 V>M No ClinGen
gnomAD
CA9078215
rs747260291
110 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA403326618
rs1323189428
112 T>S No ClinGen
TOPMed
rs1393174366
CA403326668
115 R>C No ClinGen
TOPMed
CA9078217
rs373146649
115 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1393174366
CA403326664
115 R>S No ClinGen
TOPMed
rs769917168
CA9078219
116 R>G No ClinGen
ExAC
gnomAD
rs773652238
CA9078220
116 R>M No ClinGen
ExAC
TOPMed
gnomAD
rs891620815
CA304378383
119 P>H No ClinGen
TOPMed
rs538723834
CA9078222
119 P>S No ClinGen
ExAC
gnomAD
rs1356219710
CA403326741
120 S>F No ClinGen
gnomAD
CA403326732
rs1426567806
120 S>P No ClinGen
TOPMed
rs567376375
CA9078223
121 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1467964006
CA403326762
122 P>S No ClinGen
TOPMed
CA403326771
rs1329225043
123 E>K No ClinGen
gnomAD
rs1207630921
CA403326829
126 G>D No ClinGen
gnomAD
rs763704238
CA9078225
129 T>M No ClinGen
ExAC
gnomAD
rs1271042608
CA403327079
134 T>I No ClinGen
gnomAD
CA403327115
rs1199724138
136 R>C No ClinGen
TOPMed
gnomAD
rs1568235906
CA403327116
136 R>H No ClinGen
Ensembl
CA403327137
rs1377262700
138 S>G No ClinGen
gnomAD
CA403327173
rs1477176504
139 P>L No ClinGen
gnomAD
CA304378796
rs962912288
140 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs972459532
CA304378799
141 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs1393597379
CA403327220
142 G>S No ClinGen
gnomAD
CA9078261
rs775882980
144 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA403327319
rs1230195026
147 P>S No ClinGen
gnomAD
CA403327399
rs1374334221
152 P>L No ClinGen
gnomAD
rs1267114241
CA403327391
152 P>S No ClinGen
gnomAD
rs201109329
CA9078267
153 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA9078270
rs754880818
155 N>K No ClinGen
ExAC
gnomAD
rs200311992
CA9078269
155 N>S No ClinGen
TOPMed
CA403327453
rs1190768831
156 K>E No ClinGen
gnomAD
CA9078304
rs770525245
162 R>Q No ClinGen
ExAC
TOPMed
gnomAD
COSM1564524
CA9078303
rs200022187
162 R>W Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
rs372570068
CA9078307
163 S>F No ClinGen
ESP
ExAC
gnomAD
rs760461120
CA9078309
COSM1392384
165 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs867630069
CA304379074
165 R>W No ClinGen
Ensembl
CA403327745
rs1286874273
166 K>R No ClinGen
TOPMed
CA9078310
rs764010712
169 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA304379078
rs144842420
169 R>H No ClinGen
ESP
TOPMed
gnomAD
CA403327797
rs144842420
169 R>L No ClinGen
ESP
TOPMed
gnomAD
TCGA novel 171 I>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1410591555
CA403327835
172 S>A No ClinGen
gnomAD
rs1471373235
CA403327839
172 S>C No ClinGen
gnomAD
CA403328015
rs1293528826
181 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
TCGA novel 182 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1308640029
CA403328046
183 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA403328231
rs1232933129
191 N>S No ClinGen
gnomAD
rs1484284677
CA403328290
194 D>G No ClinGen
gnomAD
TCGA novel 194 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1251805158
CA403328346
196 S>L Variant assessed as Somatic; 4.657e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA304379102
rs894122966
COSM1583006
197 S>F meninges [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
TCGA novel 199 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA304379106
rs368437366
199 N>S No ClinGen
ESP
gnomAD
TCGA novel 204 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403328453
rs1599785881
207 T>P No ClinGen
Ensembl
rs967469604
CA304379107
209 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 216 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403328549
rs1599785904
216 T>P No ClinGen
Ensembl
rs1343813496
CA403323262
221 R>Q No ClinGen
gnomAD
CA403323259
rs1317988128
221 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 224 D>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9078355
rs147158939
227 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs764538993
CA9078356
228 E>D No ClinGen
ExAC
gnomAD
CA403323327
rs1329345455
231 S>L No ClinGen
gnomAD
rs1568239317
CA403323348
235 V>M No ClinGen
Ensembl
rs1483002528
CA403323373
238 S>C No ClinGen
Ensembl
TCGA novel 240 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1287581370
CA403323409
242 N>T No ClinGen
TOPMed
rs913563071
CA304365849
244 V>A No ClinGen
TOPMed
gnomAD
rs1362229957
CA403323425
245 A>S No ClinGen
gnomAD
CA403323428
rs1479148825
245 A>V No ClinGen
gnomAD
CA304365850
rs892509493
248 T>A No ClinGen
Ensembl
CA403323454
rs765576156
249 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA403323459
rs1599792501
250 K>R No ClinGen
Ensembl
rs1371759175
CA403323478
253 V>L No ClinGen
gnomAD
rs1371759175
COSM1392389
CA403323477
253 V>M kidney Variant assessed as Somatic; 0.0 impact. large_intestine [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1599792517
CA403323500
256 W>G No ClinGen
Ensembl
CA403323516
rs1332422715
258 A>P No ClinGen
TOPMed
gnomAD
CA403323515
rs1332422715
258 A>T No ClinGen
TOPMed
gnomAD
rs754635012
CA9078378
260 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs140377183
CA304365856
266 M>T No ClinGen
1000Genomes
ESP
TOPMed
gnomAD
rs1005802358
CA304365857
267 L>M No ClinGen
TOPMed
gnomAD
CA403323603
rs1341425532
271 T>A No ClinGen
gnomAD
rs1195265864
CA403323606
271 T>M No ClinGen
gnomAD
rs992411575
CA304365859
273 R>H No ClinGen
Ensembl
CA9078380
rs752307097
274 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs745701728
CA9078403
276 A>T No ClinGen
ExAC
gnomAD
CA403323645
rs1341046528
276 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA403323651
rs1332861145
278 A>T No ClinGen
gnomAD
rs1261588912
CA403323663
279 W>* No ClinGen
gnomAD
TCGA novel 279 W>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1203796398
CA403323679
281 A>V No ClinGen
TOPMed
gnomAD
CA403323694
rs1599792873
283 Q>H No ClinGen
Ensembl
rs748622718
CA9078409
285 S>L No ClinGen
ExAC
gnomAD
TCGA novel 286 S>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1599792903
CA403323732
290 D>N No ClinGen
Ensembl
TCGA novel 291 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA9078413
rs766840993
291 R>H No ClinGen
ExAC
gnomAD
CA9078414
rs202153731
292 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA403323762
rs1414096791
294 L>Q No ClinGen
TOPMed
gnomAD
CA403323760
rs1255744202
294 L>V No ClinGen
TOPMed
rs1312286596
CA403323773
296 R>G No ClinGen
gnomAD
TCGA novel 296 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760310599
CA9078415
298 I>V No ClinGen
ExAC
gnomAD
rs763545974
CA9078416
299 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA403323798
rs763545974
299 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs200584048
CA9078417
300 T>P No ClinGen
ExAC
gnomAD
rs1227171022
CA403323806
301 P>A No ClinGen
TOPMed
CA304365869
rs910031954
301 P>L No ClinGen
TOPMed
CA403323814
rs1258167627
302 P>L No ClinGen
gnomAD
rs1210784568
CA403323832
305 S>L No ClinGen
TOPMed
gnomAD
rs868064252
CA304365870
307 R>Q No ClinGen
TOPMed
CA9078421
rs758199150
307 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA403323847
rs1249327818
308 R>Q No ClinGen
TOPMed
gnomAD
CA403323846
rs1177329604
308 R>W No ClinGen
gnomAD
rs747222804
CA9078423
311 G>A No ClinGen
ExAC
gnomAD
TCGA novel 311 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs755176269
CA9078424
315 E>G No ClinGen
ExAC
gnomAD
rs781251060
CA9078425
316 V>G No ClinGen
ExAC
gnomAD
TCGA novel 318 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403323925
rs1298840490
320 K>R No ClinGen
gnomAD
rs1372820976
CA403323937
321 W>C No ClinGen
gnomAD
rs1389905125
CA403323950
324 D>N No ClinGen
gnomAD
CA403323958
rs1161608350
325 H>N No ClinGen
TOPMed
rs1349045152
CA403323966
326 Q>* No ClinGen
gnomAD
CA403323986
rs773917396
329 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA9078428
rs773917396
329 A>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 332 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA304365935
rs902360884
342 H>Q No ClinGen
TOPMed
rs772310062
CA9078452
342 H>Y No ClinGen
ExAC
gnomAD
rs776358889
CA9078453
343 S>L No ClinGen
ExAC
gnomAD
rs776358889
CA403324096
343 S>W No ClinGen
ExAC
gnomAD
CA9078455
rs769320935
344 S>N No ClinGen
ExAC
gnomAD
rs1172815624
CA403324107
345 L>P No ClinGen
gnomAD
rs1231086900
CA403324112
346 S>N No ClinGen
gnomAD
rs762426128
CA9078458
348 V>L No ClinGen
ExAC
gnomAD
CA9078457
rs762426128
COSM994819
348 V>M Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA9078460
rs368048244
350 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs752977280
CA9078462
352 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs1599793637
CA403324166
354 H>P No ClinGen
Ensembl
rs1453955780
CA403324164
354 H>Y No ClinGen
TOPMed
rs371550562
CA9078469
362 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs371550562
CA9078468
362 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA403324238
rs1343907939
365 P>L No ClinGen
gnomAD
CA403324244
rs1417163360
366 H>R No ClinGen
gnomAD
CA403324264
rs1354267714
369 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs972485489
CA304365937
372 A>T No ClinGen
TOPMed
gnomAD
TCGA novel 373 S>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA304365939
rs866983572
376 G>D No ClinGen
Ensembl
rs1350973455 376 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1256800016
CA403324328
380 R>C No ClinGen
gnomAD
CA403324349
rs1485366651
383 R>C No ClinGen
gnomAD
CA403324352
rs1241668087
383 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs770335520
CA9078475
387 T>M No ClinGen
ExAC
gnomAD
rs1158286685
CA403324395
389 T>I No ClinGen
gnomAD
CA403324427
rs1437032816
394 Q>H No ClinGen
gnomAD
rs11542322
CA304365940
395 C>R No ClinGen
Ensembl
rs1174782457
CA403324437
396 I>V No ClinGen
gnomAD
COSM1524762
CA403324456
rs1412327723
398 T>M lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
TCGA novel 403 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403324495
rs1357788894
404 N>S No ClinGen
TOPMed
rs1291918470
CA403324516
407 W>* No ClinGen
gnomAD
TCGA novel 411 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403324546
rs1277472524
411 A>V No ClinGen
gnomAD
rs757368401
CA9078483
412 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs765625037
CA9078523
432 S>A No ClinGen
ExAC
gnomAD
CA403324712
rs1207308236
434 T>A No ClinGen
gnomAD
rs1442687365
CA403324725
436 V>M No ClinGen
TOPMed
rs753055653
CA9078526
440 T>N No ClinGen
ExAC
rs778499709
CA9078528
443 S>A No ClinGen
ExAC
gnomAD
rs1475281091
CA403324785
445 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs779667517
CA9078531
446 V>M No ClinGen
ExAC
gnomAD
TCGA novel 449 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1453727412
CA403324828
450 A>V No ClinGen
gnomAD
rs565432686
CA304366151
451 M>I No ClinGen
TOPMed
gnomAD
rs1012728735
CA304366150
451 M>T No ClinGen
TOPMed
rs1357486523
CA403324830
451 M>V No ClinGen
TOPMed
gnomAD
TCGA novel 453 P>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 457 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 458 I>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 460 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA403324895
rs1313794048
461 G>S No ClinGen
TOPMed
rs904484402
CA304366153
465 E>K No ClinGen
TOPMed
CA403324968
rs1190101490
471 N>S No ClinGen
Ensembl
rs772182014
CA9078560
472 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA9078562
rs761201993
474 S>N No ClinGen
ExAC
gnomAD
COSM1304426
CA9078563
rs376637192
477 R>C urinary_tract [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
gnomAD
rs543420977
COSM1207723
CA9078564
477 R>H large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
gnomAD
CA9078565
COSM1711610
rs762237038
478 S>L skin [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA403325011
rs1467911204
478 S>P No ClinGen
gnomAD
rs762237038
CA304366154
478 S>W No ClinGen
ExAC
TOPMed
gnomAD
rs751242023
CA9078567
479 T>R No ClinGen
ExAC
gnomAD
rs987124387
CA304366155
482 K>R No ClinGen
TOPMed
rs200327045
CA304366156
483 W>S No ClinGen
TOPMed
gnomAD
rs764162901
CA403325065
484 E>D No ClinGen
ExAC
gnomAD
CA9078592
rs753765691
485 S>A No ClinGen
ExAC
gnomAD
rs1441144502
CA403325070
485 S>C No ClinGen
gnomAD
rs1441144502
CA403325069
485 S>F No ClinGen
gnomAD
CA403325080
rs1168315113
487 S>A No ClinGen
TOPMed
rs757060869
CA9078593
487 S>Y No ClinGen
ExAC
gnomAD
rs375479536
CA9078595
490 N>S No ClinGen
ESP
ExAC
gnomAD
rs1487338135
CA403325109
492 F>L No ClinGen
gnomAD
TCGA novel 493 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1472596606
CA403325138
COSM123293
496 R>Q upper_aerodigestive_tract [Cosmic] No ClinGen
cosmic curated
gnomAD
CA403325137
rs1258445080
496 R>W No ClinGen
TOPMed
gnomAD

No associated diseases with Q9UM11

1 regional properties for Q9UM11

Type Name Position InterPro Accession
domain Signal transduction response regulator, receiver domain 10 - 147 IPR001789

Functions

Description
EC Number
Subcellular Localization
  • [Isoform 2]: Nucleus
  • ;
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
anaphase-promoting complex A ubiquitin ligase complex that degrades mitotic cyclins and anaphase inhibitory protein, thereby triggering sister chromatid separation and exit from mitosis. Substrate recognition by APC occurs through degradation signals, the most common of which is termed the Dbox degradation motif, originally discovered in cyclin B.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nuclear membrane Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

2 GO annotations of molecular function

Name Definition
anaphase-promoting complex binding Binding to an anaphase-promoting complex. A ubiquitin ligase complex that degrades mitotic cyclins and anaphase inhibitory protein, thereby triggering sister chromatid separation and exit from mitosis.
ubiquitin ligase activator activity Binds to and increases the activity of a ubiquitin ligase.

13 GO annotations of biological process

Name Definition
anaphase-promoting complex-dependent catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by the anaphase-promoting complex, and mediated by the proteasome.
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
DNA repair The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway.
lens fiber cell differentiation The process in which a relatively unspecialized cell acquires specialized features of a lens fiber cell, any of the elongated, tightly packed cells that make up the bulk of the mature lens in the camera-type eye. The cytoplasm of a lens fiber cell is devoid of most intracellular organelles including the cell nucleus, and contains primarily crystallins, a group of water-soluble proteins expressed in vary large quantities.
mitotic G2 DNA damage checkpoint signaling A mitotic cell cycle checkpoint that detects and negatively regulates progression through the G2/M transition of the cell cycle in response to DNA damage.
negative regulation of cellular senescence Any process that stops, prevents or reduces the frequency, rate or extent of cellular senescence.
positive regulation of anaphase-promoting complex-dependent catabolic process Any process that activates or increases the frequency, rate or extent of anaphase-promoting complex-dependent catabolic process.
positive regulation of cell population proliferation Any process that activates or increases the rate or extent of cell proliferation.
positive regulation of ubiquitin protein ligase activity Any process that activates or increases the frequency, rate or extent of ubiquitin protein ligase activity.
protein K11-linked ubiquitination A protein ubiquitination process in which ubiquitin monomers are attached to a protein, and then ubiquitin polymers are formed by linkages between lysine residues at position 11 of the ubiquitin monomers. K11-linked polyubiquitination targets the substrate protein for degradation. The anaphase-promoting complex promotes the degradation of mitotic regulators by assembling K11-linked polyubiquitin chains.
regulation of meiotic cell cycle Any process that modulates the rate or extent of progression through the meiotic cell cycle.
regulation of meiotic nuclear division Any process that modulates the frequency, rate or extent of meiotic nuclear division, the process in which the nucleus of a diploid cell divides twice forming four haploid cells, one or more of which usually function as gametes.
regulation of mitotic cell cycle Any process that modulates the rate or extent of progress through the mitotic cell cycle.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q960N3 cort Protein cortex Drosophila melanogaster (Fruit fly) PR
Q12834 CDC20 Cell division cycle protein 20 homolog Homo sapiens (Human) PR
Q9JJ66 Cdc20 Cell division cycle protein 20 homolog Mus musculus (Mouse) PR
Q9R1K5 Fzr1 Fizzy-related protein homolog Mus musculus (Mouse) PR
Q62623 Cdc20 Cell division cycle protein 20 homolog Rattus norvegicus (Rat) PR
Q8LPL5 FZR3 Protein FIZZY-RELATED 3 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MDQDYERRLL RQIVIQNENT MPRVTEMRRT LTPASSPVSS PSKHGDRFIP SRAGANWSVN
70 80 90 100 110 120
FHRINENEKS PSQNRKAKDA TSDNGKDGLA YSALLKNELL GAGIEKVQDP QTEDRRLQPS
130 140 150 160 170 180
TPEKKGLFTY SLSTKRSSPD DGNDVSPYSL SPVSNKSQKL LRSPRKPTRK ISKIPFKVLD
190 200 210 220 230 240
APELQDDFYL NLVDWSSLNV LSVGLGTCVY LWSACTSQVT RLCDLSVEGD SVTSVGWSER
250 260 270 280 290 300
GNLVAVGTHK GFVQIWDAAA GKKLSMLEGH TARVGALAWN AEQLSSGSRD RMILQRDIRT
310 320 330 340 350 360
PPLQSERRLQ GHRQEVCGLK WSTDHQLLAS GGNDNKLLVW NHSSLSPVQQ YTEHLAAVKA
370 380 390 400 410 420
IAWSPHQHGL LASGGGTADR CIRFWNTLTG QPLQCIDTGS QVCNLAWSKH ANELVSTHGY
430 440 450 460 470 480
SQNQILVWKY PSLTQVAKLT GHSYRVLYLA MSPDGEAIVT GAGDETLRFW NVFSKTRSTK
490
VKWESVSVLN LFTRIR